MCM2 and small cell lung carcinoma: Notably, some of the genes that make up replisome were upregulated in treatment failure patients with SCLC, e.g., cell division cycle 7 (CDC7), cell division cycle 45 (CDC45), MCM2, MCM4, MCM6, and MCM7. Control of replisome is an important concept in cancer treatment.